Chp1 was required for axon degeneration in many neurodegenerative diseases [45], and Chp2, the homologous gene of Chp1, could enhance the oncogenic potential of HEK293 cells through activating the calcineurin/nuclear factor signaling pathway in activated T cells [46]. This evidence concerns the gene CHP1 and neurodegenerative disease.